CD8A and neoplasm: The T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) is an inhibitory immune checkpoint upregulated in tumor antigen-specific CD8+ T cells and TILs of melanoma patients and is co-expressed with PD-1.